These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 7926967)
41. [Detecting expression of the multidrug resistance gene product (P170) in human tumor tissues and cells by flow cytometry]. Kan B; Luo F; Lei S; Mao Y; Zou L; Zhao X; Wei Y Hua Xi Yi Ke Da Xue Xue Bao; 1998 Sep; 29(3):269-71. PubMed ID: 10684089 [TBL] [Abstract][Full Text] [Related]
42. [Study on multidrug resistant gene (MDR1) expression between neoplastic cells and peripheral blood lymphocytes in ovarian carcinoma]. Yin G; Chen S; Sun X Zhonghua Fu Chan Ke Za Zhi; 1998 May; 33(5):287-9. PubMed ID: 10682441 [TBL] [Abstract][Full Text] [Related]
43. [Research Advance on Reversing Multidrug Resistance of Chronic Myeloid Leukemia by Chinese Herbal Monomer--Review]. Sun Y; Liu WJ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):1064-1068. PubMed ID: 32552983 [TBL] [Abstract][Full Text] [Related]
44. Correlation between the type of bcr-abl transcripts and blood cell counts in chronic myeloid leukemia - a possible influence of mdr1 gene expression. Balatzenko G; Vundinti BR; Margarita G Hematol Rep; 2011 Jan; 3(1):e3. PubMed ID: 22184525 [TBL] [Abstract][Full Text] [Related]
45. Pomolic acid-induced apoptosis in cells from patients with chronic myeloid leukemia exhibiting different drug resistance profile. Vasconcelos FC; Gattass CR; Rumjanek VM; Maia RC Invest New Drugs; 2007 Dec; 25(6):525-33. PubMed ID: 17520174 [TBL] [Abstract][Full Text] [Related]
46. Reversal of the resistance to STI571 in human chronic myelogenous leukemia K562 cells. Mukai M; Che XF; Furukawa T; Sumizawa T; Aoki S; Ren XQ; Haraguchi M; Sugimoto Y; Kobayashi M; Takamatsu H; Akiyama S Cancer Sci; 2003 Jun; 94(6):557-63. PubMed ID: 12824882 [TBL] [Abstract][Full Text] [Related]
47. P170 glycoprotein expression and impaired anthracycline retention in chronic myeloid leukaemia. Damiani D; Michieli M; Michelutti A; Fanin R; Russo D; Baccarani M Leuk Lymphoma; 1995 Apr; 17(3-4):289-94. PubMed ID: 8580798 [TBL] [Abstract][Full Text] [Related]
48. Coexpression of p53 protein and MDR functional phenotype in leukemias: the predominant association in chronic myeloid leukemia. Cavalcanti GB; Vasconcelos FC; Pinto de Faria G; Scheiner MA; de Almeida Dobbin J; Klumb CE; Maia RC Cytometry B Clin Cytom; 2004 Sep; 61(1):1-8. PubMed ID: 15351976 [TBL] [Abstract][Full Text] [Related]
49. Immunocytochemical observation of multidrug resistance (MDR) p170 glycoprotein expression in human osteosarcoma cells. The clinical significance of MDR protein overexpression. Bodey B; Taylor CR; Siegel SE; Kaiser HE Anticancer Res; 1995; 15(6B):2461-8. PubMed ID: 8669809 [TBL] [Abstract][Full Text] [Related]
50. Multidrug resistance protein expression in chronic myeloid leukemia: associations and significance. Giles FJ; Kantarjian HM; Cortes J; Thomas DA; Talpaz M; Manshouri T; Albitar M Cancer; 1999 Sep; 86(5):805-13. PubMed ID: 10463979 [TBL] [Abstract][Full Text] [Related]
51. [Cause of death, survival, and prognostic factors in a series of 98 patients with chronic myeloid leukemia]. Jonte F; Fernández-Fuertes F; Cecchini C; Luño E; Ordóñez A; Fernández C; Suárez P; Lausín A; Fernández J Sangre (Barc); 1992 Oct; 37(5):351-4. PubMed ID: 1293774 [TBL] [Abstract][Full Text] [Related]
52. Hypercalcemia in the blastic phase of chronic myeloid leukemia associated with elevated parathyroid hormone-related protein. Seymour JF; Grill V; Martin TJ; Lee N; Firkin F Leukemia; 1993 Oct; 7(10):1672-5. PubMed ID: 8412332 [TBL] [Abstract][Full Text] [Related]
53. Overexpression of MDR-related p170 glycoprotein in chronic myeloid leukemia. Michelutti A; Michieli M; Damiani D; Melli C; Geromin A; Russo D; Fanin R; Baccarani M Haematologica; 1994; 79(3):200-4. PubMed ID: 7926967 [TBL] [Abstract][Full Text] [Related]